News 

Nijmegen, 19 April 2019 - Brainclinics and Vidacto join forces to race towards a cancer-free future!

Nijmegen, April 23rd, 2019 - Dutch researchers from Research Institute Brainclinics in Nijmegen and PsyQ, (Kenniscentrum ADHD bij volwassenen) in The Hague, discovered a striking link be-tween light, sleep and ADHD, as can be read in two recent scientific publications. They published a study showing that ADHD can be a cause or a consequence of a disturbed sleep-wake rhythm. This new insight can be of great importance in the treatment of ADHD.

Sinds 2004 passen we neurofeedback gericht op het Sensori-Motor Ritme (SMR) toe bij specifieke slaapproblemen, met name inslaap- en doorslaapproblemen. Een gecontroleerd onderzoek uit 2010 liet zien dat deze methode tot objectieve verbeteringen leidde, waaronder een toename van gemiddeld bijna een uur meer slaap per nacht. In principe zijn de verbeteringen van deze behandeling blijvend en zijn geen vervolgbehandelingen meer nodig. Deze methode is nu verder ontwikkeld in een thuis te gebruiken headset en bijbehorende app, waardoor deze behandeling op een meer kosteneffectieve manier kan worden toegepast, vandaar deze evaluatie. Dit onderzoek wordt in samenwerking uitgevoerd met Onderzoeksinstituut Brainclinics en neuroCare Nijmegen.

Nijmegen, July 3rd, 2018 – Today results from the large multicenter iSPOT-A study were published in European Neuropsychopharmacology, demonstrating that brain activity can assist in predicting response to Ritalin in male adolescents with ADHD. In addition, this study clearly demonstrated gender differences in brain activity, where brain activity only predicted Ritalin response in males and not in females with ADHD. No differences in brain activity were found between children with and without ADHD, further demonstrating the value of brain imaging in prognosis rather than diagnosis.

Nijmegen, February 16th, 2018 - An international group of researchers conducted a meta-analysis that systematically looked at all available studies and found that after an intensive course of neurofeedback, the clinical benefit of neurofeedback on ADHD symptoms was maintained over a 6-month follow-up period (without treatment). At follow-up the effects of neurofeedback were not inferior to active treatments such as medication, whereas benefits for non-active control groups (such as cognitive training) were no longer present at follow-up. These results have now been published in the scientific journal European Child & Adolescent Psychiatry.

The electric brain signals, measured by using EEG, of males and females show differences. The difference can’t be detected by visual inspection, not even by the trained eye of a neurologist. A ‘deep learning’ computer is able to find it. Researchers of the University of Twente, the University of Zürich and Brainclinics research institute in Nijmegen, publish these results in Scientific Reports of 15 February.

Ben jij gezond en tussen de 18 en 60 jaar en wil jij helpen hersenstimulatie bij depressie effectiever te maken? Brainclinics zoekt momenteel gezonde volwassenen voor een onderzoek naar Neuro-Cardiac-Guided TMS ofwel NCG-TMS

Nijmegen (The Netherlands), November, 16th 2017 – Magnetic brain stimulation (rTMS) combined with concurrent psychotherapy seems more effective, then either alone, as was just published in the international journal ‘Brain Stimulation’ based on a study in 196 patients. After an average of 21 sessions, 66% of patients with treatment resistant depression responded well to treatment, with a lasting effect after 6 months in 65% of this group.

Researchers from research institute Brainclinics will present new data at the Brain Stimulation conference in Barcelona. Tabitha Iseger will present data that validate the proof-of-concept behind the new Neuro-Cardiac-Guided TMS (NCG-TMS) approach. This method could potentially become a new way to more reliably identify the right cortical locations for rTMS stimulation in the treatment of depression. Lana Donse will present some first clinical results on rTMS treatment in Obsessive Compulsive Disorder (OCD), association with sleep problems and predictors for treatment response to rTMS.

At October 26-30, researchers from Research Institute Brainclinics have presented the latest scientific results of ongoing research at the International Conference of “the International Pharmaco-EEG Society (IPEG)", which took place in Nijmegen, The Nethrlands this time.

Today results from the large multicenter randomized iSPOT-D study were published in Clinical Neurophysiology demonstrating that brain activity can assist in predicting antidepressant treatment outcome to commonly used antidepressant drugs. In addition, this study clearly demonstrated qualitative differences in brain activity between males and females with depression, with implications for predicting antidepressant treatment outcome.

A study published today in Biological Psychiatry sheds new light on the increasing rates (prevalence) of attention-deficit/hyperactivity disorder, known as ADHD. Children with ADHD have problems with inattention, distractibility, disorganization, impulsiveness, and overactivity. This study found that “sunny” regions with high solar intensity, such as the US states of California, Arizona, and Colorado, and countries like Spain and Mexico have lower prevalence of ADHD.

Today a press-release was distributed by Elsevier titled 'Do Sunny Climates Reduce ADHD?' about our study published in Biological Psychiatry.

Difficulty falling asleep and staying asleep are common symptoms in patients with ADHD, and these sleep complaints are often associated with attention and impulsivity problems, researchers from Utrecht University and research institute Brainclinics conclude in the scientific journal Neuroscience and Biobehavioural Reviews...

Nijmegen, March 27, 2012 – A personalized treatment approach, tailoring Neurofeedback treatment to the individual ADHD patient almost doubled the effectiveness for attentional and hyperactivity/impulsivity problems. These results have just been published in the scientific journal ‘Applied Psychophysiology and Biofeedback’.

Nijmegen, February 27, 2012 - Favorable treatment outcome in 78% of depressed patients after on average 21 sessions. These results were recently published based on the combination of magnetic brain stimulation (rTMS) and psycho-therapy in the treatment of depression. It was further demonstrated that by means of brain activity - or EEG research- it could be predicted which patients would respond and which patients would not respond to this treatment combination.

Antidepressiva voor mensen met een depressie en ritalin voor ADHD-patiënten. Het zijn de geijkte medicinale behandelingen bij dergelijke aandoeningen. Maar de medicijnen blijken lang niet altijd even effectief voor alle patiënten. Promovendus Martijn Arns deed onderzoek...

Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive brain stimulation technique. An electric current in a stimulation coil produces a magnetic field that induces a flow of electric current in the human brain. In combination with psychotherapy, rTMS has very good results in the treatment of depression.

Nijmegen, 28 augustus 2009 – De combinatie van gesprekstherapie en magnetische hersenstimulatie (rTMS) bij de behandeling van depressie, resulteert in een effectiviteit van 75% na gemiddeld 20 sessies. Dit zijn de resultaten van een wetenschappelijke studie die deze maand gepubliceerd wordt. De toevoeging van rTMS in gesprekstherapie heeft hetzelfde doel als antidepressiva...